The Price of Immune Responses and the Role of Vitamin D in the Inner Ear
- PMID: 31194714
- PMCID: PMC6578582
- DOI: 10.1097/MAO.0000000000002258
The Price of Immune Responses and the Role of Vitamin D in the Inner Ear
Abstract
Objective: In this review the authors discuss evidence from the literature concerning vitamin D and temporal bone diseases (benign paroxysmal positional vertigo [BPPV], Menière's disease [MD], vestibular neuritis, idiopathic facial paralysis, idiopathic acute hearing loss). Common features shared by Menière's disease, glaucoma, and the possible influence by vitamin D are briefly discussed.
Data sources, study selection: Publications from 1970 until recent times have been reviewed according to a keyword search (see above) in PubMed.
Conclusions: MD, BPPV, vestibular neuritis, idiopathic facial paralysis, idiopathic acute hearing loss may all have several etiological factors, but a common feature of the current theories is that an initial viral infection and a subsequent autoimmune/autoinflammatory reaction might be involved. Additionally, in some of these entities varying degrees of demyelination have been documented. Given the immunomodulatory effect of vitamin D, we postulate that it may play a role in suppressing an eventual postviral autoimmune reaction. This beneficial effect may be enhanced by the antioxidative activity of vitamin D and its potential in stabilizing endothelial cells. The association of vitamin D deficiency with demyelination has already been established in other entities such as multiple sclerosis and experimental autoimmune encephalitis. Mice without vitamin D receptor show degenerative features in inner ear ganglia, hair cells, as well as otoconia. The authors suggest further studies concerning the role of vitamin D deficiency in diseases of the temporal bone. Additionally, the possible presence and degree of demyelination in these entities will have to be elucidated more systematically in the future.
Figures




References
-
- Jeong SH, Kim JS, Shin JW et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol 2013;260:832–8. - PubMed
-
- Talaat HS, Abuhadied G, Talaat AS et al. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol 2015;272:2249–53. - PubMed
-
- Talaat HS, Kabel AM, Khaliel LH et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx 2016;43:237–41. - PubMed
-
- Meghji S, Murphy D, Nunney I et al. The Seasonal Variation of Benign Paroxysmal Positional Vertigo. Otol Neurotol 2017;38:1315–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical